Time to separate persistent from recurrent differentiated thyroid cancer: different conditions with different outcomes
G Sapuppo, M Tavarelli, A Belfiore… - The Journal of …, 2019 - academic.oup.com
Context Differentiated thyroid cancer (DTC) has an excellent prognosis, but up to 20% of
patients with DTC have disease events after initial treatment, indistinctly defined as …
patients with DTC have disease events after initial treatment, indistinctly defined as …
Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes
G Sapuppo, M Tavarelli, A Belfiore… - J Clin Endocrinol …, 2019 - academic.oup.com
Objective: To evaluate the prevalence and outcome of “recurrent” disease (relapse after
being 12 months disease-free) compared with “persistent” disease (present ab initio since …
being 12 months disease-free) compared with “persistent” disease (present ab initio since …
Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes.
G Sapuppo, M Tavarelli, A Belfiore… - The Journal of …, 2019 - europepmc.org
Objective To evaluate the prevalence and outcome of" recurrent" disease (relapse after
being 12 months disease-free) compared with" persistent" disease (present ab initio since …
being 12 months disease-free) compared with" persistent" disease (present ab initio since …
Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes
G Sapuppo, M Tavarelli, A Belfiore… - The Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Context Differentiated thyroid cancer (DTC) has an excellent prognosis, but up to 20% of
patients with DTC have disease events after initial treatment, indistinctly defined as …
patients with DTC have disease events after initial treatment, indistinctly defined as …
[PDF][PDF] Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes
G Sapuppo, M Tavarelli, A Belfiore, R Vigneri… - J Clin Endocrinol …, 2019 - iris.unict.it
Objective: To evaluate the prevalence and outcome of “recurrent” disease (relapse after
being 12 months disease-free) compared with “persistent” disease (present ab initio since …
being 12 months disease-free) compared with “persistent” disease (present ab initio since …
Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes
G Sapuppo, M Tavarelli, A Belfiore, R Vigneri… - Journal of Clinical …, 2019 - go.gale.com
Context: Differentiated thyroid cancer (DTC) has an excellent prognosis, but up to 20% of
patients with DTC have disease events after initial treatment, indistinctly defined as …
patients with DTC have disease events after initial treatment, indistinctly defined as …
[PDF][PDF] Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes
G Sapuppo, M Tavarelli, A Belfiore, R Vigneri… - J Clin Endocrinol …, 2019 - iris.unict.it
Objective: To evaluate the prevalence and outcome of “recurrent” disease (relapse after
being 12 months disease-free) compared with “persistent” disease (present ab initio since …
being 12 months disease-free) compared with “persistent” disease (present ab initio since …